Starpharma EV/Sales
What is the EV/Sales of Starpharma?
The EV/Sales of Starpharma Holdings Limited is 16.89
What is the definition of EV/Sales?
Enterprise value to sales ratio compares a company’s total value to its sales.
ttm (trailing twelve months)
Enterprise value/sales is a valuation ratio that compares the company's enterprise value to its annual sales. It indicates the company's capacity to generate free cash flow. In general, the lower the ratio, the cheaper the company is.
EV/Sales is most often calculated as cash and cash equivalents subtracted from the sum of market capitalization and debt and divided by annual sales. Many analysts consider EV/sales to be a more accurate metric than Price/Sales as it considers both debt and equity holders in its calculation. One of the limitations of the calculation is that sales do not take into account a company's taxes or expenses.
EV/Sales of companies in the Health Care sector on ASX compared to Starpharma
What does Starpharma do?
Starpharma Holdings Limited, a biopharmaceutical company, engages in the research, development, and commercialization of dendrimer products for pharmaceutical, life-science, and other applications worldwide. The company offers VivaGel, a non-antibiotic therapy for the management and prevention of bacterial vaginosis. It also develops VivaGel condom, an antiviral condom; and VIRALEZE, an antiviral nasal spray. In addition, the company develops DEP, a dendrimer drug delivery technology, including DEP docetaxel that is in Phase II clinical trials, DEP cabazitaxel that is in Phase II clinical trial, and DEP irinotecan that is in phase II clinical trials for the treatment of cancer; oncology programs, such as DEP radiopharmaceuticals, DEP HER-2 ADC, and DEP gemcitabine; DEP non-oncology candidates; and DEP AZD0466, which is in Phase I/II clinical trials to treat haematological tumours. The company was founded in 1996 and is headquartered in Abbotsford, Australia.
Companies with ev/sales similar to Starpharma
- Clean Seed Capital has EV/Sales of 16.86
- Brooks Automation has EV/Sales of 16.86
- Eiger BioPharmaceuticals Inc has EV/Sales of 16.87
- Desane has EV/Sales of 16.87
- Guggenheim Taxbl Muni Bnd & Invtmnt Grd Debt Trst Com Shrs Of benf Int has EV/Sales of 16.87
- Axon Enterprise Inc has EV/Sales of 16.89
- Starpharma has EV/Sales of 16.89
- Western Asset Variable Rate Strategic Fund has EV/Sales of 16.90
- Champignon Brands has EV/Sales of 16.90
- Boss Resources has EV/Sales of 16.91
- Zentalis Pharmaceuticals, Llc has EV/Sales of 16.93
- Hansa Trust A Shares has EV/Sales of 16.93
- ASLAN Pharmaceuticals Ltd has EV/Sales of 16.94